In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites
- PMID: 31707075
- DOI: 10.1016/j.biotechadv.2019.107480
In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites
Abstract
In recognition of many microorganisms ability to produce a variety of secondary metabolites in parallel, Zeeck and coworkers introduced the term "OSMAC" (one strain many compounds) around the turn of the century. Since then, additional efforts focused on the systematic characterization of a single bacterial species ability to form multiple secondary metabolite scaffolds. With the beginning of the genomic era mainly initiated by a dramatic reduction of sequencing costs, investigations of the genome encoded biosynthetic potential and especially the exploitation of biosynthetic gene clusters of undefined function gained attention. This was seen as a novel means to extend range and diversity of bacterial secondary metabolites. Genome analyses showed that even for well-studied bacterial strains, like the myxobacterium Myxococcus xanthus DK1622, many biosynthetic gene clusters are not yet assigned to their corresponding hypothetical secondary metabolites. In contrast to the results from emerging genome and metabolome mining techniques that show the large untapped biosynthetic potential per strain, many newly isolated bacterial species are still used for the isolation of only one target compound class and successively abandoned in the sense that no follow up studies are published from the same species. This work provides an overview about myxobacterial bacterial strains, from which not just one but multiple different secondary metabolite classes were successfully isolated. The underlying methods used for strain prioritization and natural product discovery such as biological characterization of crude extracts against a panel of pathogens, in-silico prediction of secondary metabolite abundance from genome data and state of the art instrumental analytics required for new natural product scaffold discovery in comparative settings are summarized and classified according to their output. Furthermore, for each approach selected studies performed with actinobacteria are shown to underline especially innovative methods used for natural product discovery.
Keywords: Actinobacteria; Bioactivity-guided isolation; Genome mining; Genomics; Myxobacteria; Natural products; Secondary metabolites; Secondary metabolomics.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest. 2019 by the authors. Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Similar articles
-
Analysis of the Genome and Metabolome of Marine Myxobacteria Reveals High Potential for Biosynthesis of Novel Specialized Metabolites.Sci Rep. 2018 Nov 9;8(1):16600. doi: 10.1038/s41598-018-34954-y. Sci Rep. 2018. PMID: 30413766 Free PMC article.
-
Supercritical Fluid Extraction Enhances Discovery of Secondary Metabolites from Myxobacteria.Anal Chem. 2020 Dec 1;92(23):15403-15411. doi: 10.1021/acs.analchem.0c02995. Epub 2020 Nov 10. Anal Chem. 2020. PMID: 33171050
-
Response of Secondary Metabolism of Hypogean Actinobacterial Genera to Chemical and Biological Stimuli.Appl Environ Microbiol. 2018 Sep 17;84(19):e01125-18. doi: 10.1128/AEM.01125-18. Print 2018 Oct 1. Appl Environ Microbiol. 2018. PMID: 30030223 Free PMC article.
-
Metabolic and Biosynthetic Diversity in Marine Myxobacteria.Mar Drugs. 2018 Sep 5;16(9):314. doi: 10.3390/md16090314. Mar Drugs. 2018. PMID: 30189599 Free PMC article. Review.
-
Investigation of cytochromes P450 in myxobacteria: excavation of cytochromes P450 from the genome of Sorangium cellulosum So ce56.FEBS Lett. 2011 Jun 6;585(11):1506-13. doi: 10.1016/j.febslet.2011.04.035. Epub 2011 Apr 22. FEBS Lett. 2011. PMID: 21521637 Review.
Cited by
-
Strong Antibiotic Activity of the Myxocoumarin Scaffold in vitro and in vivo.Chemistry. 2022 Jun 7;28(32):e202200394. doi: 10.1002/chem.202200394. Epub 2022 Apr 26. Chemistry. 2022. PMID: 35229915 Free PMC article.
-
Chromosomal organization of biosynthetic gene clusters suggests plasticity of myxobacterial specialized metabolism including descriptions for nine novel species: Archangium lansinium sp. nov., Myxococcus landrumus sp. nov., Nannocystis bainbridgea sp. nov., Nannocystis poenicansa sp. nov., Nannocystis radixulma sp. nov., Polyangium mundeleinium sp. nov., Pyxidicoccus parkwaysis sp. nov., Sorangium aterium sp. nov., Stigmatella ashevillena sp. nov.bioRxiv [Preprint]. 2023 Mar 8:2023.03.08.531766. doi: 10.1101/2023.03.08.531766. bioRxiv. 2023. PMID: 36945379 Free PMC article. Preprint.
-
The antibiotic crisis: How bacterial predators can help.Comput Struct Biotechnol J. 2020 Sep 15;18:2547-2555. doi: 10.1016/j.csbj.2020.09.010. eCollection 2020. Comput Struct Biotechnol J. 2020. PMID: 33033577 Free PMC article. Review.
-
In Silico and In Vitro Analyses Reveal Promising Antimicrobial Peptides from Myxobacteria.Probiotics Antimicrob Proteins. 2023 Feb;15(1):202-214. doi: 10.1007/s12602-022-10036-4. Epub 2022 Dec 31. Probiotics Antimicrob Proteins. 2023. PMID: 36586039 Free PMC article.
-
Combining culture optimization and synthetic biology to improve production and detection of secondary metabolites in Myxococcus xanthus: application to myxoprincomide.Microbiol Spectr. 2024 Oct 21;12(12):e0174024. doi: 10.1128/spectrum.01740-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 39431896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources